U.S. stock futures were modestly higher Tuesday, recovering from the prior session's declines as market participants processed heightened uncertainty over global trade and lingering concerns about disruptions from artificial intelligence.
Market movers in premarket trading
- Home Depot (NYSE:HD) - The home-improvement retailer's shares rose 2.1% after it reported fourth-quarter results that beat expectations and reiterated its full-year guidance. The company cited steady demand from consumers facing tighter budgets as a supporting factor.
- Novo Nordisk (CSE:NOVOb) - Shares fell 2.9% after JPMorgan lowered its rating to 'neutral' from 'overweight.' The downgrade followed late-stage data for the obesity drug CagriSema that were described as disappointing and showed the treatment to be less competitive than Eli Lilly's Zepbound.
- Keurig Dr Pepper (NASDAQ:KDP) - The soft-drinks firm climbed 2.1% after posting fourth-quarter results above expectations and providing revenue guidance for fiscal 2026 that investors found encouraging, in part based on the expected acquisition of JDE Peet's.
- DigitalOcean (NYSE:DOCN) - The cloud infrastructure provider's shares slipped 1.4% despite reporting Q4 results that exceeded forecasts and raising its revenue outlook for both 2026 and 2027. The stock has gained more than 23% year to date.
- Advanced Micro Devices (NASDAQ:AMD) - AMD jumped 10% after reaching an agreement to sell up to $60 billion worth of artificial-intelligence chips to Meta Platforms over a five-year period under terms that also permit Meta to buy as much as 10% of the chip company.
- Planet Fitness (NYSE:PLNT) - The fitness-center operator's stock dropped 4.9% after issuing a 2026 outlook that investors judged disappointing, even though fourth-quarter results beat expectations.
- Keysight Technologies (NYSE:KEYS) - Shares surged 13% after the electronic-equipment maker projected second-quarter profit ahead of Wall Street estimates.
- Hims Hers Health (NYSE:HIMS) - The telehealth company's shares fell 4.3% after it forecast first-quarter revenue that was below analyst estimates.
The premarket action underscored how company-level news - earnings beats, forward guidance and large commercial agreements - can drive outsized moves for individual stocks even as broader macro uncertainties, including trade tensions and AI-related disruption fears, weigh on overall market sentiment.
Investors continue to react to both fundamental operating signals and analysts' reassessments of competitive dynamics, as seen in the downgrade of Novo Nordisk following trial results that altered expectations for its obesity treatment relative to a key competitor.